These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38801174)

  • 21. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
    Gillard M; Fuks B; Leclercq K; Matagne A
    Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
    Ohno Y; Tokudome K
    CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension.
    Lv ZC; Li F; Wang L; Zhao QH; Gang GS; Wu Y; Miao YQ; Yuan P
    Am J Mens Health; 2021; 15(3):15579883211029458. PubMed ID: 34190625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy].
    Tokudome K; Shimizu S; Serikawa T; Ohno Y
    Nihon Yakurigaku Zasshi; 2018; 152(6):275-280. PubMed ID: 30531097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors.
    Pan YR; Song JY; Fan B; Wang Y; Che L; Zhang SM; Chang YX; He C; Li GY
    Cell Commun Signal; 2020 Feb; 18(1):27. PubMed ID: 32066462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling.
    Ohno Y; Ishihara S; Terada R; Kikuta M; Sofue N; Kawai Y; Serikawa T; Sasa M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):415-20. PubMed ID: 19751703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II.
    Li Y; Yang Y; Zhao Y; Zhang J; Liu B; Jiao S; Zhang X
    Free Radic Biol Med; 2019 Feb; 131():251-263. PubMed ID: 30502455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.
    Zhang Y; Zhang C; Li J; Jiang M; Guo S; Yang G; Zhang L; Wang F; Yi S; Wang J; Fu Y; Zhang Y
    Cell Commun Signal; 2022 Jun; 20(1):93. PubMed ID: 35715817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
    Vanoye-Carlo A; Gómez-Lira G
    Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalein attenuates caspase-independent cells death via inhibiting PARP-1 activation and AIF nuclear translocation in cerebral ischemia/reperfusion rats.
    Li WH; Yang YL; Cheng X; Liu M; Zhang SS; Wang YH; Du GH
    Apoptosis; 2020 Jun; 25(5-6):354-369. PubMed ID: 32338336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
    Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
    Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-485's anti-drug resistant epilepsy effects by regulating SV2A/PSD-95 and targeting ABCC1 and neuronal signaling-transduction proteins in hippocampus of rats.
    Wang K; Wu J; Wang J; Jiang K
    Brain Behav; 2021 Aug; 11(8):e2247. PubMed ID: 34291586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein.
    Okada M; Fukuyama K; Shiroyama T; Ueda Y
    Biomed Pharmacother; 2021 Jun; 138():111462. PubMed ID: 33706129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single dose of cocaine raises SV2A density in hippocampus of adolescent rats.
    Rossi R; Bærentzen SL; Thomsen MB; Real CC; Wegener G; Grassi-Oliveira R; Gjedde A; Landau AM
    Acta Neuropsychiatr; 2024 Apr; 36(2):109-117. PubMed ID: 36847240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramide induces macrophage migration inhibitory factor -mediated parthanatos in mouse neurons by increasing ROS levels.
    Fan C; Tian Y; Zhang Y; Teng J; Zhao X
    Neurosci Lett; 2022 Sep; 788():136862. PubMed ID: 36075319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis.
    Liu L; Li J; Ke Y; Zeng X; Gao J; Ba X; Wang R
    Cell Mol Life Sci; 2022 Jan; 79(1):60. PubMed ID: 35000037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.
    Pazarlar BA; Madsen CA; Oyar EÖ; Eğilmez CB; Mikkelsen JD
    Epilepsy Res; 2022 Jul; 183():106926. PubMed ID: 35526328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).
    Wang Y; Kim NS; Haince JF; Kang HC; David KK; Andrabi SA; Poirier GG; Dawson VL; Dawson TM
    Sci Signal; 2011 Apr; 4(167):ra20. PubMed ID: 21467298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.
    Contreras-García IJ; Gómez-Lira G; Phillips-Farfán BV; Pichardo-Macías LA; García-Cruz ME; Chávez-Pacheco JL; Mendoza-Torreblanca JG
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33922424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.